Voting is a privilege of living in a democratic society, and, for people with disabilities, it is one of the most important ways to promote leaders that best represent your values. But the voice of the disability community is only as loud and as strong as the number of disability advocates that are registered to . . .
In addition to MDA’s dedication to funding research and providing multidisciplinary clinical care, we are also passionate and committed advocates for the families we serve. Together, we advocate for increased federal funding for biomedical research; for access to clinical care, support services and equipment; and for policies and programs that help ensure access to the . . .
In the U.S., a disease is considered “rare” if it impacts fewer than 200,000 people. This broad definition encompasses almost 7,000 diseases —including those under MDA’s umbrella—and includes millions of Americans. In fact, 1 out of every 10 people in the U.S. are currently living with a disease that is classified as “rare.” When considered . . .
If you are interested in muscular dystrophy research, you need to know about the MDCC… What is the MDCC? You may have previously come across the acronym “MDCC” posted on MDA’s website or social media pages. MDCC stands for the Muscular Dystrophy Coordinating Committee. The Committee was established under the MD-CARE . . .